The desirable properties of criteria for reporting and grading toxicity are discussed from a biological and clinical perspective.
In 1996, 2001, and 2010, the Consolidated Standards of Reporting Trials (CONSORT) group released criteria for reporting critical information about randomized clinical trials [1,2].
Two studies fully met the criteria for reporting choice of health outcomes as others did not specify the relevance of those chosen [2, 10].
A mixture of studies fully or partially met criteria for reporting target population, setting/location, comparators, estimating resources and costs, and currency.
The CET was designed to guide employers in using Just Culture principles when reviewing practice errors and to clarify the criteria for reporting nurses to the BON.
Bicket and his team examined more than 2,400 prior studies but found only six that met their criteria for reporting on unused opioid medication.
Both of them are the most widely accepted criteria for reporting quality assessment in acupuncture studies.
The criteria for reporting an outcome as complete response (CR) were defined as follows: marrow aspirate with less than 5% leukemic blasts, neutrophils greater than 1,000/mcL, platelets greater than 100,000/mcL and no residual evidence of extramedullary disease.
Three articles fulfilled the criteria for reporting high-quality studies.
Surveillance case definitions provide uniform criteria for reporting notifiable diseases.
